AskTheDate.com
Back to calendar

Spyre Therapeutics, Inc. (SYRE) Earnings

SYRE reports earnings on Thursday, August 6, 2026

earnings report
August 6, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.76
Actual EPS: $-0.74
EPS surprise: -11.17%
Company overview
Market Cap$8.6B
PriceUSD 98.95
EPS (TTM)-2.36
52-week high105.09
52-week low14.51
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees102